Skip to main content

SNGX

Stock
Health Care
Biotechnology

Performance overview

SNGX Price
Price Chart

Forward-looking statistics

Beta
0.47
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

soligenix, inc. is a late stage biopharmaceutical company committed to developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense. soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous t-cell lymphoma, oral mucositis, pediatric crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis.

Company info

SectorHealth Care
IndustryBiotechnology
Employees19
Market cap$3.7M

Fundamentals

Enterprise value-$2.9M
Revenue$2.3K
Revenue per employee—
Profit margin0.00%
Debt to equity2.19

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$3.13
Dividend per share—
Revenue per share$0.00
Avg trading volume (30 day)$6M
Avg trading volume (10 day)$17M
Put-call ratio—

Macro factor sensitivity

Growth+6.3
Credit+27.5
Liquidity-14.1
Inflation+0.1
Commodities+0.4
Interest Rates-3.7

Valuation

Dividend yield0.00%
PEG Ratio-0.24
Price to sales1672.60
P/E Ratio-0.24
Enterprise Value to Revenue-1256.09
Price to book1.06

Upcoming events

Next earnings dayMay 9, 2025
Next dividend day—
Ex. dividend day—

News

Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why

Soligenix Inc SNGX shares surged on Tuesday on a heavy volume of 23.6 million as per data from Benzinga Pro.

Benzinga (July 9, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free